Total cholesterol levels and mortality risk in nonischemic systolic heart failure

American Heart Journal

Volumn 152, Issue 6, 2006, Pages 1077-1083

  Afsarmanesh, Nasim ^a   Horwich, Tamara B ^a   Fonarow, Gregg C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; FEMALE; HAZARD ASSESSMENT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATIENT REFERRAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; STATISTICAL ANALYSIS;

ADULT; CARDIAC OUTPUT, LOW; CHOLESTEROL; COHORT STUDIES; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; ROC CURVE; STROKE VOLUME; SYSTOLE;

EID: 33845185821     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.06.015     Document Type: Article

References (26)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Kannel W.B., and Belanger A.J. Epidemiology of heart failure. Am Heart J 121 (1991) 951-957
3. Horwich T.B., Hamilton M.A., Maclellan W.R., et al. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 8 (2002) 216-224
4. Rauchhaus M., Clark A.L., Doehner W., et al. The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 42 (2003) 1933-1940
5. Rauchhaus M., Coats A.J., and Anker S.D. The endotoxin-lipoprotein hypothesis. Lancet 356 (2000) 930-933
6. Christ M., Klima T., Grimm W., et al. Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy. Eur Heart J 27 (2006) 691-699
7. Fonarow G.C., Stevenson L.W., Walden J.A., et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 30 (1997) 725-732
8. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
9. Stevenson L.W., Tillisch J.H., Hamilton M., et al. Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 66 (1990) 1348-1354
10. Pekkanen J., Linn S., Heiss G., et al. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 322 (1990) 1700-1707
11. Schatz I.J., Masaki K., Yano K., et al. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet 358 (2001) 351-355
12. Tikhonoff V., Casiglia E., Mazza A., et al. Low-density lipoprotein cholesterol and mortality in older people. J Am Geriatr Soc 53 (2005) 2159-2164
13. Elliott D.C., and Wiles III C.E. Low lipid concentrations in critical illness: hypocholesterolemia among trauma patients. Crit Care Med 25 (1997) 1437-1439
14. Fraunberger P., Nagel D., Walli A.K., et al. Serum cholesterol and mortality in patients with multiple organ failure. Crit Care Med 28 (2000) 3574-3575
15. Liu Y., Coresh J., Eustace J.A., et al. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 291 (2004) 451-459
16. Anand I.S., Latini R., Florea V.G., et al. C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation 112 (2005) 1428-1434
17. Deswal A., Petersen N.J., Feldman A.M., et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103 (2001) 2055-2059
18. Niebauer J., Volk H.D., Kemp M., et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353 (1999) 1838-1842
19. Harris H.W., Grunfeld C., Feingold K.R., et al. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 86 (1990) 696-702
20. Rauchhaus M., Koloczek V., Volk H., et al. Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol 76 (2000) 125-133
21. Anker S.D., Steinborn W., and Strassburg S. Cardiac cachexia. Ann Med 36 (2004) 518-529
22. Anker S.D., Ponikowski P., Varney S., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349 (1997) 1050-1053
23. Cowie M.R., Wood D.A., Coats A.J., et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart 83 (2000) 505-510
24. Foody J.M., Shah R., Galusha R., et al. Statins and mortality among elderly patients hospitalized with heart failure. Circulation 113 (2006) 86-92
25. Mozaffarian D., Nye R., and Levy W.C. Statin therapy is associated with lower mortality among patients with severe heart failure. Am J Cardiol 93 (2004) 1124-1129
26. Horwich T.B., MacLellan W.R., and Fonarow G.C. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. J Am Coll Cardiol 43 (2004) 642-648